Safety of KAI-9803 for Injection With Angioplasty Following Heart Attack

Clinical trial NCT00093197 · COMPLETED

Trial details

NCT number: NCT00093197
Sponsor: KAI Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myocardial Infarction

Start date: 2004-09-01
Primary completion: 2006-10-01
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.